down arrow

Zim Laboratories

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE518E01015
  • NSEID: ZIMLAB
  • BSEID: 541400
INR
87.89
1.24 (1.43%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 33.42 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

86.0087.90

52 Week

79.64131.30
Valuation
Technical
Day's Volume

CASH

33.42 k (-28.04%) Volume

Shareholding (Dec 2024)

FII

0.21%

Held by 3 FIIs

DII

0.24%

Held by 0 DIIs

Promoter

33.26%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 9.55%

  • Poor long term growth as Net Sales has grown by an annual rate of 5.07% and Operating profit at 16.41% over the last 5 years
2

The company has declared Negative results for the last 3 consecutive quarters

3

Stock is technically in a Bearish range

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 428 Cr (Micro Cap)

stock-summary
P/E

27.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.39

stock-summary
Return on Equity

6.65%

stock-summary
Price to Book

1.74

Revenue and Profits (1 Year):
Net Sales:
96 Cr
(Quarterly Results - Dec 2024)
Net Profit:
4 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-17.74%
0%
-17.74%
1 Year
-9.71%
0%
-9.71%
2 Years
12.97%
0%
12.97%
3 Years
-45.1%
0%
-45.1%
4 Years
21.9%
0%
21.9%
5 Years
20.89%
0%
20.89%

Latest dividend: 0.5 per share ex-dividend date: Sep-19-2019

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
5.07%
EBIT Growth (5y)
16.41%
EBIT to Interest (avg)
3.30
Debt to EBITDA (avg)
2.00
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.29
Tax Ratio
26.47%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.45%
ROCE (avg)
9.39%
ROE (avg)
7.73%
Valuation key factors
Factor
Value
P/E Ratio
27
Industry P/E
33
Price to Book Value
1.74
EV to EBIT
19.86
EV to EBITDA
11.55
EV to Capital Employed
1.53
EV to Sales
1.33
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.98%
ROE (Latest)
6.65%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 3 FIIs (0.21%)

Promoter with highest holding

Anwar Daud (27.37%)

Highest Public shareholder

Zakir S Vali (10.36%)

Individual Investors Holdings

44.39%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 0.04% vs -4.64% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -16.32% vs -27.58% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "96.33",
          "val2": "96.29",
          "chgp": "0.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11.56",
          "val2": "11.54",
          "chgp": "0.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.73",
          "val2": "1.70",
          "chgp": "60.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.00",
          "val2": "4.78",
          "chgp": "-16.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.00%",
          "val2": "11.98%",
          "chgp": "0.02%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 13.51% vs -20.23% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -25.11% vs -58.68% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "173.97",
          "val2": "153.27",
          "chgp": "13.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17.57",
          "val2": "14.15",
          "chgp": "24.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.75",
          "val2": "2.95",
          "chgp": "94.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.28",
          "val2": "4.38",
          "chgp": "-25.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.10%",
          "val2": "9.23%",
          "chgp": "0.87%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 8.31% vs -14.86% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -20.52% vs -46.74% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "270.30",
          "val2": "249.56",
          "chgp": "8.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29.13",
          "val2": "25.69",
          "chgp": "13.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.48",
          "val2": "4.65",
          "chgp": "82.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.28",
          "val2": "9.16",
          "chgp": "-20.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.78%",
          "val2": "10.29%",
          "chgp": "0.49%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -7.81% vs 19.52% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -29.39% vs 67.90% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "367.42",
          "val2": "398.53",
          "chgp": "-7.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "41.33",
          "val2": "51.99",
          "chgp": "-20.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "6.92",
          "val2": "5.58",
          "chgp": "24.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "17.25",
          "val2": "24.43",
          "chgp": "-29.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.25%",
          "val2": "13.05%",
          "chgp": "-1.80%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
96.33
96.29
0.04%
Operating Profit (PBDIT) excl Other Income
11.56
11.54
0.17%
Interest
2.73
1.70
60.59%
Exceptional Items
0.00
0.00
Consolidate Net Profit
4.00
4.78
-16.32%
Operating Profit Margin (Excl OI)
12.00%
11.98%
0.02%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 0.04% vs -4.64% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is -16.32% vs -27.58% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
173.97
153.27
13.51%
Operating Profit (PBDIT) excl Other Income
17.57
14.15
24.17%
Interest
5.75
2.95
94.92%
Exceptional Items
0.00
0.00
Consolidate Net Profit
3.28
4.38
-25.11%
Operating Profit Margin (Excl OI)
10.10%
9.23%
0.87%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 13.51% vs -20.23% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -25.11% vs -58.68% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
270.30
249.56
8.31%
Operating Profit (PBDIT) excl Other Income
29.13
25.69
13.39%
Interest
8.48
4.65
82.37%
Exceptional Items
0.00
0.00
Consolidate Net Profit
7.28
9.16
-20.52%
Operating Profit Margin (Excl OI)
10.78%
10.29%
0.49%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 8.31% vs -14.86% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -20.52% vs -46.74% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
367.42
398.53
-7.81%
Operating Profit (PBDIT) excl Other Income
41.33
51.99
-20.50%
Interest
6.92
5.58
24.01%
Exceptional Items
0.00
0.00
Consolidate Net Profit
17.25
24.43
-29.39%
Operating Profit Margin (Excl OI)
11.25%
13.05%
-1.80%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -7.81% vs 19.52% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -29.39% vs 67.90% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Zim Laboratories Ltd stock-summary
stock-summary
Zim Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Zim Laboratories Ltd was incorporated in February, 1984 under the name and style of Zim Laboratories Private Limited in the State of Maharashtra. The Company became a Public Limited Company through fresh Certificate of Incorporation issued by the Registrar of Companies, Maharashtra, Mumbai. The Company is engaged in the manufacturing of formulation on drugs and pre formulation ingredients in India and marketing and selling these within and outside India.
Company Coordinates stock-summary
Company Details
Sadoday Gyan (Gr Floor), Opp NADT Nelson Square Nagpur Maharashtra : 440013
stock-summary
Tel: 91-712-2588070
stock-summary
http://www.zimlab.in
stock-summary
md@zimlab.in
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."